Drug Therapy, Other

Citations 291-300 of 395 total displayed.

Past content (since Mar 1999):

Original Investigations
Association Between Mental Health Disorders, Problem Drug Use, and Regular Prescription Opioid Use

Mark D. Sullivan; Mark J. Edlund; Lily Zhang; Jürgen Unützer; Kenneth B. Wells
Arch Intern Med 2006; 166: 2087-2093. [Abstract] [Full text] [PDF]  

Original Investigations
High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus Infections: Efficacy and Toxicity

Levita K. Hidayat; Donald I. Hsu; Ryan Quist; Kimberly A. Shriner; Annie Wong-Beringer
Arch Intern Med 2006; 166: 2138-2144. [Abstract] [Full text] [PDF]  

Editor's Correspondence
Infliximab and Human Immunodeficiency Virus Infection: Viral Load Reduction and CD4⁺ T-Cell Loss Related to Apoptosis

Jérôme Filippi; Pierre-Marie Roger; Stéphane M. Schneider; Jacques Durant; Jean-Philippe Breittmayer; Sylvia Benzaken; Alain Bernard; Pierre Dellamonica; Xavier Hébuterne; for the Groupe d’Etude Niçois Polyvalent en Infectiologie(GENPI)
Arch Intern Med 2006; 166: 1783-1784. [Extract] [Full text] [PDF]  

Editor's Correspondence
Corticosteroids and Atrial Fibrillation: Risks or Benefits?

Tong Liu; Guangping Li
Arch Intern Med 2006; 166: 1785-a-1786-a. [Extract] [Full text] [PDF]  

Editor's Correspondence
Corticosteroids in Atrial Fibrillation: Friends or Foes?

Panagiotis Korantzopoulos
Arch Intern Med 2006; 166: 1785. [Extract] [Full text] [PDF]  

Editor's Correspondence
It Is Time to Stop Comparing Blood Pressure–Lowering Drugs With Placebo—Reply

Roberto Ferrari; for the PREAMI Investigators
Arch Intern Med 2006; 166: 1786-a-1787-a. [Extract] [Full text] [PDF]  

Editor's Correspondence
It Is Time to Stop Comparing Blood Pressure–Lowering Drugs With Placebo

Flávio Danni Fuchs
Arch Intern Med 2006; 166: 1786. [Extract] [Full text] [PDF]  

Editorials
New Weapon to Curb Smoking: No More Excuses to Delay Treatment

Bankole A. Johnson
Arch Intern Med 2006; 166: 1547-1550. [Extract] [Full text] [PDF]  

Review Articles
Cytisine for Smoking Cessation: A Literature Review and a Meta-analysis

Jean-François Etter
Arch Intern Med 2006; 166: 1553-1559. [Abstract] [Full text] [PDF]  

Original Investigations
Smoking Cessation With Varenicline, a Selective 42 Nicotinic Receptor Partial Agonist: Results From a 7-Week, Randomized, Placebo- and Bupropion-Controlled Trial With 1-Year Follow-up

Mitchell Nides; Cheryl Oncken; David Gonzales; Stephen Rennard; Eric J. Watsky; Rich Anziano; Karen R. Reeves; for the Varenicline Study Group
Arch Intern Med 2006; 166: 1561-1568. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40